Insight Genome brings whole genome sequencing to the forefront of personalized medicine
Huntsville, Ala. — HudsonAlpha Institute for Biotechnology announced today the Insight Genome for individuals interested in unlocking the secrets of their genome, or genetic code. The clinical program will be housed at Smith Family Clinic for Genomic Medicine on the HudsonAlpha campus.
Insight Genome was developed specifically to tell patients today about their risks for developing specific medical conditions– or passing them onto their children– and to help inform future healthcare decisions.
“Whole genome sequencing offers information not found in one comprehensive tool elsewhere,” said Howard Jacob, PhD, HudsonAlpha executive vice president for genomic medicine. “Many people have heard us talk about rare, undiagnosed disease and how do we apply this technology, but the holy grail is how do we deploy this for everybody?” said Jacob.
Insight Genome is comprised of two elements, all based on your personal genome:
- A clinical report. This is medical information you and your physician can use.
- Pharmacogenomic report from Kailos Genetics (pharmacogenomics are how your genes impact your response to medications).
“One question that I am continually asked is when can I sequence my genome?” said Neil Lamb, PhD, HudsonAlpha vice president for educational outreach. “We are now able to explore how whole genome sequencing can become transformative for clinical care, and also engage both physicians and patients.”
The first step in getting an Insight Genome is a physician referral to Smith Family Clinic for Genomic Medicine. You must be 19 years of age or older.
For more information, visit smithfamilyclinic.org/insightgenome.
About HudsonAlpha: HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to innovating in the field of genomic technology and sciences across a spectrum of biological challenges. Opened in 2008, its mission is four-fold: sparking scientific discoveries that can impact human health and well-being; bringing genomic medicine into clinical care; fostering life sciences entrepreneurship and business growth; and encouraging the creation of a genomics-literate workforce and society. The HudsonAlpha biotechnology campus consists of 152 acres nestled within Cummings Research Park, the nation’s second largest research park. Designed to be a hothouse of biotech economic development, HudsonAlpha’s state-of-the-art facilities co-locate nonprofit scientific researchers with entrepreneurs and educators. The relationships formed on the HudsonAlpha campus encourage collaborations that produce advances in medicine and agriculture. Under the leadership of Dr. Richard M. Myers, a key collaborator on the Human Genome Project, HudsonAlpha has become a national and international leader in genetics and genomics research and biotech education, and includes more than 30 diverse biotech companies on campus. To learn more about HudsonAlpha, visit: http://hudsonalpha.org/.
HudsonAlpha Media Contact: